awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38807514-2E9E3F0C-D95D-435D-AC5D-66464DA233DF
Q38807514-2E9E3F0C-D95D-435D-AC5D-66464DA233DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38807514-2E9E3F0C-D95D-435D-AC5D-66464DA233DF
CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.
P2860
Q38807514-2E9E3F0C-D95D-435D-AC5D-66464DA233DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38807514-2E9E3F0C-D95D-435D-AC5D-66464DA233DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
922b5f5a318b419f118a4541c177f6738c240ecb
P2860
A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disorders